#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour of the lung HER2 gene amplification Acquired haemophilia Immunodeficiency congenital Small cell lung cancer Osteosarcoma recurrent Synovial sarcoma metastatic Penile cancer Chronic lymphocytic leukaemia refractory Liposarcoma recurrent Guillain-Barre syndrome Gastric cancer Adenomatous polyposis coli Cardiac failure acute Thrombocytopenia More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Treatment Leiomyosarcoma – Basic Information Immunodeficiency congenital – Life with Disease Paraneoplastic neurological syndrome – Treatment Osteosarcoma metastatic – Life with Disease Mastocytosis – Basic Information Primary biliary cholangitis – Treatment Systemic sclerosis pulmonary – Diagnostics Rosai-Dorfman syndrome – Basic Information Pemphigus – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olaparib ULVIPRUBART Batoclimab Ciprofloxacin Hydrochloride Levothyroxine Sodium Oric-114 Apg777 Follitropin Delta Gallium (68Ga) Evx-01 Zanamivir Larotrectinib Sulfate ANTI-GD2-800CW Nmd670 Ddcart‐Cd19 Imidapril Hydrochloride Glucose, Anhydrous Raludotatug Deruxtecan Trametinib Dimethyl Sulfoxide Human Mesenchymal Stem Cells More therapies…

    Learn about Your Condition

    Andersen-Tawil syndrome Aortic valve disease Carcinoid tumour pulmonary Anal cancer metastatic Pouchitis Leiomyosarcoma Portal hypertension Drug dependence Cutaneous T-cell lymphoma Intracranial aneurysm Neoplasm malignant Generalised anxiety disorder Type IIa hyperlipidaemia Malabsorption Haemorrhoids More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Deep vein thrombosis

  • Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

    Recruiting

    3 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Deep vein thrombosis postoperative
    • Pelvic venous thrombosis
    Investigated Drugs:
    • Rosuvastatin Calcium
    France Norway

  • Study on the Best Antithrombotic Therapy for Patients with Acute Venous Thromboembolism Using Tinzaparin Sodium and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • D,L-Lysine Acetylsalicylate
    • Fondaparinux Sodium
    France

  • A study to evaluate the use of colchicine to reduce inflammation in patients with deep vein thrombosis.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Pelvic venous thrombosis
    Investigated Drugs:
    • Colchicine
    Italy

  • Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Thrombolysis
    Investigated Drugs:
    • Bay 3018250
    Belgium Bulgaria Czechia France Germany Greece +5

  • Study on Dabigatran, Apixaban, Rivaroxaban, and Edoxaban for Patients with Atrial Fibrillation, Deep Vein Thrombosis, or Pulmonary Embolism

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Pulmonary embolism
    • Atrial fibrillation
    Investigated Drugs:
    • Dabigatran Etexilate
    • Apixaban
    • Rivaroxaban
    Denmark

  • Study on Apixaban for Preventing Blood Clots in Leg Veins During Long-Distance Flights for Travelers at Risk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apixaban
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!